![Joshua Zeidner: Important results from ENHANCE-3 by Naval Daver](https://oncodaily.com/pub/uploads/2024/06/mm-e1718476754739-1280x721.jpg)
Photo taken from Joshua Zeidner/X
Jun 18, 2024, 06:04
Joshua Zeidner: Important results from ENHANCE-3 by Naval Daver
Joshua Zeidner, Associate Professor at UNC Lineberger, shared on X:
“Disappointing but important results from ENHANCE-3 by Naval Daver. We need to learn from these negative trials to design the optimal studies, protocols, and dosing schedules in the future. Still unclear why there were more infection-related deaths with Magrolimab. ”
Source: Joshua Zeidner/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 10, 2024, 18:47
Sep 10, 2024, 17:17